An individualized care plan follows and is designed to overcome metabolic challenges, including proprietary, medically curated peptides, including GLP-1s when appropriate
Ozempic has gained in popularity due to off-label use, meaning its use for conditions not directly tested in a clinical trial or not approved by the FDA
Its important that we remain amenable to new ideas while exercising the appropriate caution
In some patients, sleep disturbances were present even after 12-month post C-19, with negative impact on patients quality of life
May 13, 2025: Study Says More People Lose Weight on Zepbound Than Wegovy According to a new study that examined post-clinical trial data, people lost more weight on Zepbound than Wegovy
It accounts for about 70% of all bariatric surgeries and leads to an average weight loss of about 25%